Page last updated: 2024-11-08

biguanides and Dyslipidemia

biguanides has been researched along with Dyslipidemia in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jellinger, PS1
Rabasseda, X1

Reviews

1 review available for biguanides and Dyslipidemia

ArticleYear
Metabolic consequences of hyperglycemia and insulin resistance.
    Clinical cornerstone, 2007, Volume: 8 Suppl 7

    Topics: Biguanides; Cannabinoid Receptor Modulators; Cardiovascular Diseases; Dyslipidemias; Fatty Acids, No

2007

Other Studies

1 other study available for biguanides and Dyslipidemia

ArticleYear
From insulin to incretins: a report from the 67th scientific sessions of the American Diabetes Association.
    Timely topics in medicine. Cardiovascular diseases, 2007, Aug-01, Volume: 11

    Topics: Biguanides; Diabetes Complications; Diabetes Mellitus; Diet; Dietary Supplements; Dipeptidyl-Peptida

2007